Abera Bioscience AB engages in the research and development of pharmaceutical products. Its project includes Vaccine and Pneumococcal Vaccine. The company was founded by Joen Luirink on November 3, 2012 and is headquartered in Uppsala, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company